Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 147,789 | 156,599 | 306,239 | 248,343 | 274,019 |
| Marketable Securities | 264,455 | 243,022 | 119,543 | 179,959 | 144,912 |
| Receivables | 57,667 | 48,639 | 50,599 | 42,610 | 41,491 |
| Inventories | 27,033 | 27,466 | 27,533 | 27,019 | 23,378 |
| TOTAL | $511,056 | $490,883 | $516,500 | $509,001 | $494,853 |
| Non-Current Assets | |||||
| PPE Net | 8,438 | 8,376 | 8,617 | 8,464 | 8,702 |
| Investments And Advances | 3,445 | 3,432 | 18,077 | 34,332 | 0 |
| Other Non-Current Assets | 6,946 | 7,046 | 6,806 | 6,797 | 6,983 |
| TOTAL | $18,829 | $18,854 | $33,500 | $49,593 | $15,685 |
| Total Assets | $529,885 | $509,737 | $550,000 | $558,594 | $510,538 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,889 | 6,254 | 14,356 | 8,622 | 12,024 |
| Accrued Expenses | 75,300 | 75,212 | 87,565 | 69,265 | 79,711 |
| TOTAL | $93,498 | $85,157 | $105,514 | $81,637 | $95,390 |
| Non-Current Liabilities | |||||
| Long Term Debt | 819,297 | 746,933 | 733,279 | 713,648 | 622,182 |
| Deferred Revenues | 1,779 | 1,200 | 1,224 | 1,554 | 1,521 |
| Other Non-Current Liabilities | 0 | 0 | 4,027 | 0 | 0 |
| TOTAL | $825,100 | $752,867 | $739,083 | $719,616 | $628,380 |
| Total Liabilities | $918,598 | $838,024 | $844,597 | $801,253 | $723,770 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 189,494 | 188,935 | 188,451 | 186,424 | 185,945 |
| Common Shares | 1,895 | 1,889 | 1,879 | 1,864 | 1,859 |
| Retained earnings | -1,583,279 | -1,507,953 | -1,454,620 | -1,383,079 | -1,340,559 |
| Other shareholders' equity | 690 | 585 | 26 | -98 | 15 |
| TOTAL | $-388,713 | $-328,287 | $-294,597 | $-242,659 | $-213,232 |
| Total Liabilities And Equity | $529,885 | $509,737 | $550,000 | $558,594 | $510,538 |